Back to Journals » Cancer Management and Research » Volume 10

Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2

Total article views   Abstract views HTML views PDF downloads Totals
4,569 Dovepress* 4,186 239+ 349 4,425
PubMed Central* 0 144 49 144
Totals 4,186 383 398 4,569
*Since 9 October 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar